Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Dementia research collaborations

Dementias Platform UK (DPUK) is a public-private partnership funded by the Medical Research Council. We work across traditional boundaries and bring researchers together to free the world from dementia. Our mission is to innovate dementia research collaborations and cohort data studies so we can detect and treat dementia earlier than ever before. DPUK's Data Portal is at our hear and is the UK's richest source of cohort data.

 

Dementia affects over 50 million people globally and the challenge to society will only increase unless we develop new approaches to research. We need to bridge the knowledge gap between basic science and new treatments. DPUK is helping fill this gap by providing unprecedented access to cohort data and to the latest technological networks that enable high-quality experimental studies that we so badly need.

 

Since its launch in 2015 DPUK has increased the capacity of dementia research by delivering national technological networks, dementia research collaborations, and cohort data accessible to researchers worldwide. This powerful combination of technology and expertise is helping detect the earliest signs of dementia so we can treat them before dementia emerges.

 

DPUK is achieving this step-change in dementia research through:

 

The imaging and stem cell technology networks

DPUK brings together skilled scientists, from both industry and universities, to use state-of-the-art technology in developing new approaches to research.

 

The Data Portal

DPUK is giving researchers rapid online access to unprecedented amounts of cohort data –  genetics, imaging and medical records – to generate insights into aging, diseases, and dementia risk.

 

Experimental medicine

DPUK is increasing the capacity and precision of experimental medicine to improve trial success and develop new treatments.

 

Academic-industry partnerships

Collaborating and partnering with industry, using pre-competitive space for knowledge sharing and hypothesis testing in experimental studies that show which drugs work best in which people.

Our partners 

Cambridge

Araclon Biotech
Cardiff
AstraZeneca
GSK Edinburgh Invicro Imperial
Kings College London IXICO Manchester janssen
Somalogic swansea_university_logo UCL Newcastle-University-logo
Oxford wide UniversityofExetercolour_logo.jpg responsive_image.jpg Cognetivity_primary-colour.png